Breaking News
3 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Leinco and CellCarta partner to integrate proteomics tools for biomarker discovery in oncology and targeted therapy development.
Pharma Now Editorial Team

Merck secures FDA priority review for KEYTRUDA and KEYTRUDA QLEX plus Padcev in bladder cancer, accelerating manufacturing and supply chain decisions.
Pharma Now Editorial Team

Asahi Kasei completes Aicuris acquisition, targeting severe infectious diseases and a global specialty pharma platform.
Pharma Now Editorial Team

Ipsen's tovorafenib becomes the EU's first targeted therapy for relapsed or refractory pediatric low-grade glioma, backed by Phase II FIREFLY-1 data.
Pharma Now Editorial Team
